Prelude Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,027
| Closed | -$31.9K | – | 1045 |
|
|
2025
Q1 | $31.9K | Buy |
+10,027
| New | +$31.9K | ﹤0.01% | 1023 |
|
|
2018
Q3 | – | Sell |
-939
| Closed | -$10K | – | 1396 |
|
|
2018
Q2 | $10K | Buy |
+939
| New | +$10K | ﹤0.01% | 1199 |
|
|
2017
Q2 | – | Sell |
-14,852
| Closed | -$308K | – | 1519 |
|
|
2017
Q1 | $308K | Buy |
14,852
+5,450
| +58% | +$113K | 0.03% | 385 |
|
|
2016
Q4 | $134K | Buy |
+9,402
| New | +$134K | 0.02% | 697 |
|